Articles tagged with Gastrointestinal Tract
Researchers at MedUni Vienna studied Covid-19's impact on lungs and colon, identifying novel biomarkers and treatment strategies. SARS-CoV-2 infections evoke different molecular mechanisms in pulmonary and gastrointestinal manifestations.
A new study of over 8 million pregnancies found that pregnant women with inflammatory bowel disease (IBD) are at a higher risk of gestational diabetes, postpartum hemorrhage, and other complications. IBD can also lead to longer hospital stays and increased medical costs.
A world-first study has confirmed the link between Alzheimer's Disease and multiple gut disorders, revealing shared genetic architecture. The study suggests that abnormal cholesterol levels play a key role in both conditions, and may lead to new potential treatments for Alzheimer's and gut disorders.
Researchers identify key enzyme CbrR and cyclic-di-GMP as crucial for Campylobacter jejuni's motility and biofilm formation. By targeting these elements, scientists aim to develop a safe molecule to prevent infection.
Patients who use cannabis require higher levels of sedation during gastric endoscopies than non-users, according to research. Cannabis use is associated with increased odds of requiring higher total sedation during gastroscopy but not colonoscopy.
Patients who use cannabis require more drugs than non-users during gastric endoscopies, according to a study. Researchers found that cannabis use was associated with increased odds of requiring higher sedation levels during gastroscopy but not colonoscopy.
A new study published in Proceedings of the National Academy of Sciences found that mice with different gut microbiomes choose different diets, influenced by substances produced by microbes. The researchers suggest that certain molecules, such as tryptophan, may be hijacking the body's natural signals to promote specific food cravings.
A new device made from silicone and liquid metal, with knotted cords, measures pressure in the digestive tract similar to high-resolution manometry. The invention brings down cost and makes it easier to produce and deploy, offering a cheaper alternative for diagnosing dysmotility disorders.
Researchers at Penn Medicine have discovered a new approach to treat solid cancers using CDH17CAR T cells, which selectively target and eliminate gastrointestinal (GI) solid tumors like gastric, pancreatic, and colorectal cancers in preclinical models. Unlike other immunotherapies, CDH17CAR T cells do not show toxicity to healthy tissues.
Researchers at Karolinska Institutet used spatial transcriptomics to create a map of gene expression in the mouse colon, gaining new insights into inflammatory bowel disease. The study's findings suggest that the colon is divided into more segments than previously thought and could lead to the development of new treatments.
A team of researchers discovered that chance plays a significant role in the formation of individual gut microbiomes, with genetic, diet, and environmental factors influencing the odds of colonization. The study's findings have major implications for treatments like fecal transplants and probiotics.
A team led by Case Western Reserve University discovered the novel repair properties of Gasdermin B protein, promoting restoration of epithelial layers and effective wound-healing. The findings have significant implications for designing therapeutics to enhance wound repair in various organs.
Researchers at MIT have developed a pill that can deliver RNA to the stomach, potentially making vaccines easier to tolerate and treat gastrointestinal diseases. The capsule is designed to release RNA in the stomach, where it can stimulate an immune response without being degraded by digestive enzymes.
A study by Kennedy Krieger Institute explores how GI problems in children with autism affect their families. Researchers identified four main themes: anxiety, diet, microbiome imbalance, and medication impact. The findings highlight the need for interventions to address poor gut health and its consequences.
A new study found that a specific type of carbohydrate called ‘fodmaps’ can aggravate intestinal problems, but its impact is not as significant as previously believed. IBS symptoms were found to be influenced more by psychological factors and individual differences in metabolism and intestinal flora.
Researchers identified predictive molecular biomarkers for non-response to anti-TNF and anti-integrin therapies in UC. Biomarkers in innate and adaptive immune systems, as well as proteolytic degradation, were found to be predictive of therapy non-response.
A study published in Scientific Reports demonstrates the use of positron emission tomography (PET) imaging to track the elimination of plastic particles from the bodies of mice. The research reveals that most small plastic particles are eliminated within two days, with smaller particles cleared faster than larger ones.
Researchers developed a noninvasive diagnostic imaging tool to measure the levels of bile salt hydrolase in the gastrointestinal tract, predicting clinical status and efficacy of probiotic supplements. The tool also evaluates prebiotics' ability to increase bile salt-hydrolase activity, offering new insights into personalized health care.
The chemical synthesis of trefoil factor peptide TFF1 enables the study of its mechanisms of action and optimization for therapeutic applications. The new method provides novel insights into the protein's interactions with mucins, accelerating wound healing in the gastrointestinal tract.
A study found that US adults with inflammatory bowel disease tend to eat more junk food, such as French fries, cheese, and cookies, which may contribute to their condition. The research also revealed that these foods can increase the risk of inflammatory bowel disease.
New research from Brown University shows how Candida albicans fungus can adapt to different host environments. The study found that patient samples of the fungus frequently lack one copy of a gene that serves as a vital master regulator, allowing cells to switch phenotype and thrive in various environments.
Researchers at Mount Sinai discover that an antimicrobial protein in the gut can prevent graft-versus-host-disease, a common and lethal side effect of bone marrow transplants. The protein, REG3α, may lead to new treatments for inflammatory bowel disease and other GI illnesses.
Researchers have successfully powered small electronic devices in the gastrointestinal tract using mid-field wireless powering, a technique that operates at higher frequencies for more efficient delivery. This breakthrough could transform disease diagnosis and treatment by enabling implantable devices to operate wirelessly.
Researchers developed a sensor that uses Raman spectroscopy to detect molecular markers of IBD in the colon, helping to distinguish between ulcerative colitis and Crohn's disease. The device could provide an objective gold standard for diagnosis and guide personalized treatment approaches.
Researchers design a new type of extended-release pill that can attach to the gastrointestinal tract lining and release its contents slowly. The dual-sided device uses mucoadhesives and omniphobic materials to resist being pulled away by food and liquids.
A study found that severe burns alter bacteria populations dramatically, leading to a decrease in beneficial bacteria and an increase in potentially harmful Enterobacteriaceae. This imbalance may contribute to sepsis and other infectious complications in burn patients.
A study of patients treated with warfarin suggests that resuming therapy after gastrointestinal tract bleeding is associated with a lower risk of blood clots and death. The analysis found that resuming warfarin was linked to a significantly increased risk of thrombosis and death from any cause if therapy was not resumed.
Research reveals vitamin A's dual role in immune response, producing regulatory T cells to dampen inflammation while stimulating pro-inflammatory responses to combat infection. The study highlights the importance of nutritional status in regulating the immune system.
A recent study found that patients taking celecoxib (a COX-2 selective NSAID) had lower rates of gastrointestinal adverse events compared to those taking diclofenac slow release plus omeprazole. The CONDOR study suggests that celecoxib may be a safer option for arthritis patients at increased gastrointestinal risk.
The Mayo Clinic research team identified genetic variants in serotonin genes that impact IBS, suggesting a complex molecular mechanism involving multiple genes. The study found several previously unknown associations between IBS and serotonin-related SNPs, providing new insights into the condition.
A new study found that whole milk is just as effective as a diluted barium suspension in imaging the gastrointestinal tract via CT scans. The study also revealed that whole milk was less expensive, had better patient acceptance, and fewer adverse symptoms compared to the barium suspension.
Multidetector CT (MDCT) technology can accurately detect bowel perforations without the need for contrast media, making it a game-changer in emergency medicine. The study found that MDCT correctly identified bowel perforation in 73 of 85 patients.
A clinical trial shows that Garli-Eze, a unique garlic product, can deliver large amounts of allicin directly to the upper gastrointestinal tract for easy absorption. This process eliminates degradation issues and allows for effective cardiovascular benefits.
A high-fiber diet helps keep the gut healthy by increasing mucus production in gut cells. The new research reveals that roughage damages cell membranes, triggering a natural repair response that exudes lubricating mucus, easing digestion and reducing discomfort.